Literature DB >> 6106258

The prevalence of presumed tardive dyskinesia in psychiatric inpatients and outpatients.

J Kane, J Wegner, S Stenzler, P Ramsey.   

Abstract

Randomly selected psychiatric patients (271 total) were examined by raters blind to diagnosis and treatment history for the presence of abnormal movements. The prevalence of presumed tardive dyskinesia among neuroleptic-exposed patients was 4.6%. If minimal rating scale criteria were applied, 9% of those patients with no history of neuroleptic exposure might have been given 'presumptive' diagnoses of dyskinesia. Problems in establishing diagnostic criteria are discussed and a longitudinal approach toward validating diagnoses is recommended.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6106258     DOI: 10.1007/bf00433090

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  6 in total

1.  On the methods and theory of reliability.

Authors:  J J Bartko; W T Carpenter
Journal:  J Nerv Ment Dis       Date:  1976-11       Impact factor: 2.254

2.  The assessment of tardive dyskinesia.

Authors:  G Gardos; J O Cole; R La Brie
Journal:  Arch Gen Psychiatry       Date:  1977-10

3.  Dopaminergic hypersensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesia.

Authors:  J Gerlach; N Reisby; A Randrup
Journal:  Psychopharmacologia       Date:  1974-01-09

4.  A rating scale for tardive dyskinesia.

Authors:  G M Simpson; J H Lee; B Zoubok; G Gardos
Journal:  Psychopharmacology (Berl)       Date:  1979-08-08       Impact factor: 4.530

5.  [Significance of trigeminal degeneration in speech disorders in hereditary ataxia].

Authors:  R STOLZE; G ULE
Journal:  Nervenarzt       Date:  1957-01-20       Impact factor: 1.214

6.  Dyskinesias associated with tricyclic antidepressants.

Authors:  W E Fann; J L Sullivan; B W Richman
Journal:  Br J Psychiatry       Date:  1976-05       Impact factor: 9.319

  6 in total
  2 in total

Review 1.  Assessment of extrapyramidal disorders.

Authors:  C D Marsden; M Schachter
Journal:  Br J Clin Pharmacol       Date:  1981-02       Impact factor: 4.335

2.  The impact of neuroleptic medication on tardive dyskinesia: a meta-analysis of published studies.

Authors:  H Morgenstern; W M Glazer; D Niedzwiecki; P Nourjah
Journal:  Am J Public Health       Date:  1987-06       Impact factor: 9.308

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.